233 related articles for article (PubMed ID: 22569136)
1. Time dependent neuroprotection of mycophenolate mofetil: effects on temporal dynamics in glial proliferation, apoptosis, and scar formation.
Ebrahimi F; Koch M; Pieroh P; Ghadban C; Hobusch C; Bechmann I; Dehghani F
J Neuroinflammation; 2012 May; 9():89. PubMed ID: 22569136
[TBL] [Abstract][Full Text] [Related]
2. The immunosuppressant mycophenolate mofetil attenuates neuronal damage after excitotoxic injury in hippocampal slice cultures.
Dehghani F; Hischebeth GT; Wirjatijasa F; Kohl A; Korf HW; Hailer NP
Eur J Neurosci; 2003 Sep; 18(5):1061-72. PubMed ID: 12956706
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of microglial and astrocytic inflammatory responses by the immunosuppressant mycophenolate mofetil.
Dehghani F; Sayan M; Conrad A; Evers J; Ghadban C; Blaheta R; Korf HW; Hailer NP
Neuropathol Appl Neurobiol; 2010 Dec; 36(7):598-611. PubMed ID: 20609108
[TBL] [Abstract][Full Text] [Related]
4. Ethyl pyruvate does not require microglia for mediating neuroprotection after excitotoxic injury.
Pieroh P; Wagner DC; Ghadban C; Birkenmeier G; Dehghani F
CNS Neurosci Ther; 2017 Oct; 23(10):798-807. PubMed ID: 28836378
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury.
Di Giovanni S; Movsesyan V; Ahmed F; Cernak I; Schinelli S; Stoica B; Faden AI
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8333-8. PubMed ID: 15923260
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures.
Hailer NP; Vogt C; Korf HW; Dehghani F
Eur J Neurosci; 2005 May; 21(9):2347-60. PubMed ID: 15932594
[TBL] [Abstract][Full Text] [Related]
7. Microglia-Dependent and Independent Brain Cytoprotective Effects of Mycophenolate Mofetil During Neuronal Damage.
Kleine J; Hohmann U; Hohmann T; Ghadban C; Schmidt M; Laabs S; Alessandri B; Dehghani F
Front Aging Neurosci; 2022; 14():863598. PubMed ID: 35572146
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures.
Kreutz S; Koch M; Ghadban C; Korf HW; Dehghani F
Exp Neurol; 2007 Jan; 203(1):246-57. PubMed ID: 17010339
[TBL] [Abstract][Full Text] [Related]
9. Successful inhibition of excitotoxic neuronal damage and microglial activation after delayed application of interleukin-1 receptor antagonist.
Vogt C; Hailer NP; Ghadban C; Korf HW; Dehghani F
J Neurosci Res; 2008 Nov; 86(15):3314-21. PubMed ID: 18646209
[TBL] [Abstract][Full Text] [Related]
10. 2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells.
Kreutz S; Koch M; Böttger C; Ghadban C; Korf HW; Dehghani F
Glia; 2009 Feb; 57(3):286-94. PubMed ID: 18837048
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion.
Hauser IA; Renders L; Radeke HH; Sterzel RB; Goppelt-Struebe M
Nephrol Dial Transplant; 1999 Jan; 14(1):58-63. PubMed ID: 10052478
[TBL] [Abstract][Full Text] [Related]
12. Astrocytic factors protect neuronal integrity and reduce microglial activation in an in vitro model of N-methyl-D-aspartate-induced excitotoxic injury in organotypic hippocampal slice cultures.
Hailer NP; Wirjatijasa F; Roser N; Hischebeth GT; Korf HW; Dehghani F
Eur J Neurosci; 2001 Jul; 14(2):315-26. PubMed ID: 11553282
[TBL] [Abstract][Full Text] [Related]
13. The immunosuppressant mycophenolate mofetil improves preservation of the perforant path in organotypic hippocampal slice cultures: a retrograde tracing study.
Oest TM; Dehghani F; Korf HW; Hailer NP
Hippocampus; 2006; 16(5):437-42. PubMed ID: 16598730
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil attenuates myocardial ischemia-reperfusion injury via regulation of the TLR4/NF-κB signaling pathway.
Li T; Yu J; Chen R; Wu J; Fei J; Bo Q; Xue L; Li D
Pharmazie; 2014 Nov; 69(11):850-5. PubMed ID: 25985583
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis is not enhanced in primary mixed neuronal/glial cultures protected by isoflurane against N-methyl-D-aspartate excitotoxicity.
Wise-Faberowski L; Aono M; Pearlstein RD; Warner DS
Anesth Analg; 2004 Dec; 99(6):1708-1714. PubMed ID: 15562059
[TBL] [Abstract][Full Text] [Related]
16. Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells.
Morath C; Zeier M
Int J Clin Pharmacol Ther; 2003 Oct; 41(10):465-9. PubMed ID: 14703952
[TBL] [Abstract][Full Text] [Related]
17. IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells.
Takebe N; Cheng X; Fandy TE; Srivastava RK; Wu S; Shankar S; Bauer K; Shaughnessy J; Tricot G
Mol Cancer Ther; 2006 Feb; 5(2):457-66. PubMed ID: 16505121
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis of superantigen-activated T cells induced by mycophenolate mofetil treatment.
Izeradjene K; Revillard JP
Transplantation; 2001 Jan; 71(1):118-25. PubMed ID: 11211176
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil in solid-organ transplantation.
Srinivas TR; Kaplan B; Meier-Kriesche HU
Expert Opin Pharmacother; 2003 Dec; 4(12):2325-45. PubMed ID: 14640931
[TBL] [Abstract][Full Text] [Related]
20. Suppression by mycophenolate mofetil of the neointimal thickening caused by vascular injury in a rat arterial stenosis model.
Fraser-Smith EB; Rosete JD; Schatzman RC
J Pharmacol Exp Ther; 1995 Dec; 275(3):1204-8. PubMed ID: 8531082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
